Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor

Acta Neuropathologica

Volumn 123, Issue 2, 2012, Pages 285-287

  Ellezam, Benjamin ^a,b   Theeler, Brett J ^a   Luthra, Rajyalakshmi ^a   Adesina, Adekunle M ^b   Aldape, Kenneth D ^a   Gilbert, Mark R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; TEMOZOLOMIDE;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE FUSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; LETTER; MALE; METASTASIS; MISSENSE MUTATION; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; ONCOGENE; PIK3CA GENE; PRIORITY JOURNAL; RECURRENT DISEASE; ROSETTE FORMING GLIONEURONAL TUMOR;

ADOLESCENT; ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PHOSPHATIDYLINOSITOL 3-KINASES; YOUNG ADULT;

EID: 84857034489     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-011-0886-z     Document Type: Letter

References (15)

1. C Bettegowda N Agrawal Y Jiao, et al. 2011 Mutations in CIC and FUBP1 contribute to human oligodendroglioma Science 333 1453 1455 21817013 10.1126/science.1210557 1:CAS:528:DC%2BC3MXhtFWqurnF
2. DK Broderick C Di TJ Parrett YR Samuels JM Cummins RE McLendon DW Fults VE Velculescu DD Bigner H Yan 2004 Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res 64 5048 5050 15289301 10.1158/0008-5472.CAN-04-1170 1:CAS:528:DC%2BD2cXmtF2mtrk%3D (Pubitemid 39006515)
3. A Broniscer SJ Baker AN West, et al. 2007 Clinical and molecular characteristics of malignant transformation of low-grade glioma in children J Clin Oncol 25 682 689 17308273 10.1200/JCO.2006.06.8213 1:CAS:528: DC%2BD2sXjt1Kgu7Y%3D (Pubitemid 350002924)
4. Gessi M, Waha A, Setty P, Pietsch T (2011) Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT). Neuropathology. doi: 10.1111/j.1440-1789.2011.01220.x
5. Hainfellner JA, Scheithauer BW, Giangaspero F, Rosenblum MK (2007) Rosette-forming glioneuronal tumour of the fourth ventricle. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon, pp 115-116
6. C Hartmann G Bartels C Gehlhaar N Holtkamp A von Deimling 2005 PIK3CA mutations in glioblastoma multiforme Acta Neuropathol 109 639 642 15924253 10.1007/s00401-005-1000-1 1:CAS:528:DC%2BD2MXls1Smsb0%3D (Pubitemid 40974153)
7. C Hartmann L Devermann C Gehlhaar N Holtkamp A von Deimling 2006 PIK3CA mutations in oligodendroglial tumours Neuropathol Appl Neurobiol 32 209 212 16599949 10.1111/j.1365-2990.2006.00700.x 1:CAS:528:DC%2BD28XkslantLc%3D
8. TS Jacques C Eldridge A Patel NM Saleem M Powell ND Kitchen M Thom T Revesz 2006 Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation Neuropathol Appl Neurobiol 32 217 220 16599951 10.1111/j.1365-2990.2005.00692.x 1:STN:280:DC%2BD287psFGisA%3D%3D
9. D Koul 2008 PTEN signaling pathways in glioblastoma Cancer Biol Ther 7 1321 1325 18836294 10.4161/cbt.7.9.6954 1:CAS:528:DC%2BD1cXhsVKms7%2FJ
10. EF Rodriguez BW Scheithauer C Giannini A Rynearson L Cen B Hoesley H Gilmer-Flynn JN Sarkaria S Jenkins J Long FJ Rodriguez 2011 PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma Acta Neuropathol 121 407 420 21113787 10.1007/s00401-010-0784-9 1:CAS:528:DC%2BC3MXhvVyrsro%3D
11. Y Samuels Z Wang A Bardelli, et al. 2004 High frequency of mutations of the PIK3CA gene in human cancers Science 304 554 15016963 10.1126/science. 1096502 1:CAS:528:DC%2BD2cXjsVGmsbk%3D (Pubitemid 38541907)
12. H Sasaki MC Zlatescu RA Betensky Y Ino JG Cairncross DN Louis 2001 PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis Am J Pathol 159 359 367 11438483 10.1016/S0002-9440(10)61702-6 1:CAS:528:DC%2BD3MXlslalsr4%3D (Pubitemid 33704221)
13. G Schindler D Capper J Meyer, et al. 2011 Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma Acta Neuropathol 121 397 405 21274720 10.1007/s00401-011-0802-6 1:CAS:528:DC%2BC3MXhvVyrsrk%3D
14. RK Thomas AC Baker RM DeBiasi, et al. 2007 High-throughput oncogene mutation profiling in human cancer Nat Genet 39 347 351 17293865 10.1038/ng1975 1:CAS:528:DC%2BD2sXitVOktrs%3D (Pubitemid 46328493)
15. W Wick M Weller M Weiler T Batchelor AW Yung M Platten 2011 Pathway inhibition: emerging molecular targets for treating glioblastoma Neuro Oncol 13 566 579 21636705 10.1093/neuonc/nor039 1:CAS:528:DC%2BC3MXpsVCqu7g%3D